In Memoriam: Pelayo Correa (1927–2025)
Pelayo Correa, born in Sonsón, Antioquia, in 1927, was one of the most influential figures in cancer epidemiology and pathology in Latin America and worldwide. His work transformed the understanding of gastric carcinogenesis and gave rise to one of the most solid and longstanding population-based registries on the continent. His scientific life - defined by rigor, curiosity, and public service - leaves an enduring legacy for generations of researchers. Professor Correa graduated as a physician from the University of Antioquia in 1949, where he completed his thesis on cancer statistics in the department —pioneering work that sparked his lifelong interest in differences in cancer risk across populations. This early study took him to Emory University in the United States, where he trained as a pathologist and solidified his etiologic vocation: to understand the causes of disease, not only its morphological expression. After completing his training, he returned to Colombia and joined the Universidad del Valle. During a 1961 congress, his presentation on cancer patterns in Cali drew the attention of Dr. Harold Stewart of the National Cancer Institute (NCI), who shared the data with Dr. William Haenszel. From that exchange, Dr. Haenszel traveled to Cali and, together with Professor Correa, helped establish the Cali Population-Based Cancer Registry (RPCC), the first in Latin America and today one of the oldest in the world. Dr. Haenszel also served as his mentor in epidemiology, contributing to the design and conduct of the investigations that followed in subsequent decades, aimed at clarifying the determinants of gastric cancer. The strength of the Cali Registry became evident early on. The RPCC publication in the Journal of the National Cancer Institute in April 1966 coincided with the release of the first volume of Cancer Incidence in Five Continents(January 1966), which included RPCC data. This convergence placed the Cali registry within the foundational landmarks of global cancer surveillance. At a time when the world was beginning to standardize comparative incidence measurement, Professor Correa’s work provided rigorous data from Latin America, demonstrating that his epidemiological vision was not only aligned with global developments but contributed to them from the outset.
- Front Matter
2
- 10.1016/j.jtho.2021.12.002
- Mar 17, 2022
- Journal of Thoracic Oncology
Lung Cancer in Sudan
- Research Article
2
- 10.1158/1055-9965.epi-10-0523
- Jul 1, 2010
- Cancer Epidemiology, Biomarkers & Prevention
Despite steady decreases in the cancer burden in industrialized countries, its rapid increase in the developing world means that the number of cancer cases and deaths will likely more than double worldwide over the next two decades ([1][1]). Already a leading cause of death around the globe, cancer
- Discussion
95
- 10.1378/chest.12-1699
- Feb 1, 2013
- Chest
Epidemic of Lung Cancer in Patients With HIV Infection
- Front Matter
48
- 10.1016/j.gie.2014.06.006
- Jul 15, 2014
- Gastrointestinal Endoscopy
Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer
- Research Article
110
- 10.1016/j.juro.2006.10.071
- Feb 10, 2007
- Journal of Urology
Bladder Cancer Incidence and Risk Factors in Men With Prostate Cancer: Results From Cancer of the Prostate Strategic Urologic Research Endeavor
- Research Article
70
- 10.4103/0256-4947.67078
- Jan 1, 2010
- Annals of Saudi Medicine
BACKGROUND AND OBJECTIVES:Despite its relatively low incidence in Saudi Arabia, breast cancer has been the most common cancer among Saudi females for the past 12 consecutive years. The objective of this study was to report the results of the first national public breast cancer screening program in Saudi Arabia.METHODS:Women 40 years of age or older underwent breast cancer screening. Mammograms were scored using the Breast Imaging-Reporting and Data System (BI-RADS). Correlations between imaging findings, risk factors and pathological findings were analyzed.RESULTS:Between September 2007 and April 2008, 1215 women were enrolled. The median age was 45 years, and median body mass index was 31.6 kg/m2. Sixteen cases of cancer were diagnosed. No cancer was diagnosed in 942 women with R1/R2 scores, and only 1 case of cancer was diagnosed in 228 women with R0/R3 scores. However, among 26 women with R4/R5 scores, 50% had malignant disease and 35% had benign lesions. No correlation was found between known risk factors and imaging score or cancer diagnosis.CONCLUSIONS:Public acceptance of the breast cancer screening program was encouraging. Longitudinal follow-up will help in better determining the risk factors relevant to our patient population.
- Front Matter
51
- 10.1093/annonc/mdn561
- Oct 1, 2008
- Annals of Oncology
Diet, nutrition and cancer: public, media and scientific confusion
- Research Article
33
- 10.1002/ijc.11480
- Sep 16, 2003
- International Journal of Cancer
Second primary cancers after thymoma
- Research Article
61
- 10.1053/j.gastro.2006.01.031
- Feb 1, 2006
- Gastroenterology
New Developments in Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) and Mismatch Repair Gene Testing
- Research Article
34
- 10.1053/j.gastro.2021.06.079
- Aug 17, 2021
- Gastroenterology
Diversity and Inclusion in Pancreatic Cancer Clinical Trials
- Research Article
133
- 10.1016/j.jaci.2005.04.006
- Jun 1, 2005
- Journal of Allergy and Clinical Immunology
Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology
- Research Article
7
- 10.1097/ju.0000000000001531
- Dec 22, 2020
- Journal of Urology
Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial
- Research Article
20
- 10.1111/dech.12496
- Mar 1, 2019
- Development and Change
Global Development, Converging Divergence and Development Studies: A Rejoinder
- Research Article
33
- 10.1158/1055-9965.epi-09-1027
- Nov 1, 2009
- Cancer Epidemiology, Biomarkers & Prevention
Cholesterol and Cancer: Answers and New Questions
- Research Article
139
- 10.1089/jayao.2011.1505
- Mar 1, 2011
- Journal of Adolescent and Young Adult Oncology
What Should the Age Range Be for AYA Oncology?
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.